# Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

> **NCT03088046** · NA · COMPLETED · sponsor: **Fundacion Dexeus** · enrollment: 15 (actual)

## Conditions studied

- Anovulation
- Polycystic Ovary Syndrome
- Hyperandrogenism

## Interventions

- **DRUG:** Micronized Progesterone

## Key facts

- **NCT ID:** NCT03088046
- **Lead sponsor:** Fundacion Dexeus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03088046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03088046, "Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03088046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*